| CNPAX | GFFDX | CNPAX / GFFDX | |
| Total Expense Ratio | 0.77 | 0.87 | 89% |
| Annual Report Gross Expense Ratio | 0.77 | 0.87 | 89% |
| Fund Existence | 24 years | 7 years | - |
| Gain YTD | 16.484 | 11.924 | 138% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 159B | 572M | 27,797% |
| Annual Yield % from dividends | 0.45 | 0.00 | - |
| Returns for 1 year | 11.66 | 13.13 | 89% |
| Returns for 3 years | 47.09 | 83.19 | 57% |
| Returns for 5 years | 27.82 | 16.90 | 165% |
| Returns for 10 years | 95.85 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MQQQ | 176.82 | 1.68 | +0.96% |
| Tradr 2X Long Innovation 100 Monthly ETF | |||
| BBC | 33.79 | 0.04 | +0.12% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| BBSC | 70.77 | -0.01 | -0.02% |
| JPMorgan BetaBuilders US Sml Cp Eq ETF | |||
| BTA | 9.41 | -0.05 | -0.53% |
| Blackrock Long-Term Municipal Advantage Trust | |||
| IDV | 37.34 | -0.28 | -0.74% |
| iShares International Select Div ETF | |||